Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia

被引:0
|
作者
Ramezanali, Fariba [1 ]
Khalili, Gholamreza [2 ]
Arabipoor, Arezoo [1 ]
Lankarani, Narges Bagheri [2 ]
Moini, Ashraf [1 ]
机构
[1] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Endocrinol & Female Infertil, POB 16635-148, Tehran, Iran
[2] ACECR, Royan Inst Reprod Biomed, Reprod Epidemiol Res Ctr, Dept Epidemiol & Reprod Hlth, Tehran, Iran
关键词
Polycystic Ovary Syndrome; Endometrial Hyperplasia; Luteinizing Hormone; Body Mass Index;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The endometrial hyperplasia measured by ultrasound in polycystic ovary syndrome (PCOS) women is strongly related to pathologic endometrial thickness, but there is no consensus on the relation between serum luteinizing hormone (LH) and either of these factors: pathologic endometrial hyperplasia and body mass index (BMI). Materials and Methods: In this observational cross-sectional study, three hundred fifty infertile PCOS women were involved in this research. An endometrial biopsy was taken by using a pipelle instrument, regardless of menstrual cycle's day and all samples were reported by the same pathologist. Basal serum LH level was compared between two subgroups (hyperplasia and non-hyperplasia). The intended population was divided into three groups according to BMI and basal serum LH, later on the comparison was made in three groups. Chi-square test was applied to compare nominal variables between groups. Mann-Whitney U, and one way ANOVA tests were used to compare means on the basis of the result of normality test. Results: The frequency of endometrial hyperplasia was 2.6%. Endometrial thickness in the patients with endometrial hyperplasia was significantly higher than that of a normal endometrium (10.78 +/- 3.70 vs. 7.90 +/- 2.86 respectively, P=0.020). There was no relation between endometrial hyperplasia and serum LH (P=0.600). The ANOVA test showed serum LH levels were not the same among three BMI groups (P=0.007). Post hoc test was also performed. It showed that the LH level in normal BMI group was significantly higher than those of other groups (P=0.005 and P=0.004), but there was no statistical difference between overweight and obese groups (P=0.8). We found no relationship between BMI and endometrial thickness in PCOS patients (P=0.6). Conclusion: Sonographic endometrial stripe thickness is predictive for endometrial hyperplasia in PCOS women. We could not find out any relationship between serum LH level and BMI with endometrial thickness in PCOS patients. However, our study confirmed a diverse relationship between serum LH level and BMI in PCOS patients.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [11] Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome
    Cortet-Rudelli, C
    Pigny, P
    Decanter, C
    Leroy, M
    Maunoury-Lefebvre, C
    Thomas-Desrousseaux, P
    Dewailly, D
    FERTILITY AND STERILITY, 2002, 77 (02) : 281 - 287
  • [12] LUTEINIZING HORMONE: FOLLICLE-STIMULATING HORMONE RATIO, BODY MASS INDEX, DISTURBANCES IN SACCHAROMETABOLISM AND LIPOMETABOLISM INTERDEPENDENCE IN POLYCYSTIC OVARY SYNDROME
    Chen, J.
    Du, M. M.
    Xiao, D.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (01): : 145 - 150
  • [13] Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
    Senturk, Senol
    Hatirnaz, Safak
    Kanat-Pektas, Mine
    MEDICAL SCIENCE MONITOR, 2018, 24 : 7517 - 7523
  • [14] Plasma luteinizing hormone level affects the brain activity of patients with polycystic ovary syndrome
    Lai, Wanlin
    Li, Xuan
    Zhu, Huili
    Zhu, Xi
    Tan, Huiwen
    Feng, Peimin
    Chen, Lei
    Luo, Cheng
    PSYCHONEUROENDOCRINOLOGY, 2020, 112
  • [15] Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome
    Brower, M. A.
    Hai, Y.
    Jones, M. R.
    Guo, X.
    Chen, Y. -D. I.
    Rotter, J. I.
    Krauss, R. M.
    Legro, R. S.
    Azziz, R.
    Goodarzi, M. O.
    HUMAN REPRODUCTION, 2019, 34 (01) : 127 - 136
  • [16] Leptin levels in serum and body mass index in patients with endometrial cancer
    Uchikova, E.
    Dimitrakova, E.
    Uchikov, P.
    Orbecova, M.
    Amaliev, G.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2016, 38 (01): : 223 - 225
  • [17] Leptin levels in serum and body mass index in patients with endometrial cancer
    Uchikova, E.
    Dimitrakova, E.
    Uchikov, P.
    Orbecova, M.
    Amaliev, G.
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 112 - 112
  • [18] The connections between serum anti-mullerian hormone and metabolic parameters in polycystic ovary syndrome patients vary depending on body mass index category
    Albu, A.
    Albu, D.
    Radian, S.
    Florea, S.
    Fica, S.
    HUMAN REPRODUCTION, 2015, 30 : 421 - 421
  • [19] Pharmacokinetic factors contribute to the inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome
    Srouji, Serene S.
    Pagan, Yanira L.
    D'Amato, Fernando
    Dabela, Amsalu
    Jimenez, Yarisie
    Supko, Jeffrey G.
    Hall, Janet E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1347 - 1352
  • [20] Correlations between dietary intake or body mass index and serum androgen in women with polycystic ovary syndrome
    Wang, Ting-Wen
    Chao, Jane C-J
    Wei, Hsiao-Jui
    Young, Robert
    Liaw, Chian-Mey
    Wang, Szu-Shun
    Jiang, Bo-Shu
    Ho, Hsin-Jung
    FASEB JOURNAL, 2010, 24